ClearPoint Neuro, Inc. — Director's Dealing 2019

Aug 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MRI INTERVENTIONS, INC. (MRIC)
CIK: 0001285550
Period of Report: 2019-08-15

Reporting Person: BURNETT JOSEPH MICHAEL (Director, CEO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-15	Common Stock	A	36023	$0.00	Acquired	263328	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-15	Stock Options (right to buy)	$3.47	A	74404	Acquired	2029-08-15	Common Stock (74404)	Direct

Footnotes

F1: The shares are restricted stock and vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.

F2: The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.